Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2247)
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
55,121
Price
$8.01
Total Value
$441.52K
Shares Held After
190,130
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
525,844
Price
$8.01
Total Value
$4.21M
Shares Held After
1,813,795
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
2,419,035
Price
$8.01
Total Value
$19.38M
Shares Held After
10,112,123
% of Holdings
19.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
WILLIAMS ROBERT M JR — 10% Owner
Shares
55,121
Price
$8.01
Total Value
$441.52K
Shares Held After
190,130
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
WILLIAMS ROBERT M JR — 10% Owner
Shares
525,844
Price
$8.01
Total Value
$4.21M
Shares Held After
1,813,795
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
WILLIAMS ROBERT M JR — 10% Owner
Shares
2,419,035
Price
$8.01
Total Value
$19.38M
Shares Held After
10,112,123
% of Holdings
19.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
J.H. Whitney Equity Partners VII, LLC — 10% Owner
Shares
2,419,035
Price
$8.01
Total Value
$19.38M
Shares Held After
10,112,123
% of Holdings
19.3%
Ceribell, Inc. (CBLL)
BURKE WILLIAM W — Director
Shares
2,207
Price
$19.84
Total Value
$43.79K
Shares Held After
23,022
% of Holdings
8.7%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,255
Price
$24.98
Total Value
$106.29K
Shares Held After
41,688
% of Holdings
10.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,638
Price
$23.88
Total Value
$39.12K
Shares Held After
37,433
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,910
Price
$22.95
Total Value
$43.83K
Shares Held After
35,795
% of Holdings
5.3%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
25,027
Price
$17.13
Total Value
$428.79K
Shares Held After
9,212,252
% of Holdings
0.3%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
6,755
Price
$3.23
Total Value
$21.82K
Shares Held After
78,597
% of Holdings
8.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
30,703
Price
$35.49
Total Value
$1.09M
Shares Held After
93,969
% of Holdings
24.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
27,872
Price
$35.48
Total Value
$988.89K
Shares Held After
58,750
% of Holdings
32.2%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
10,833
Price
$16.02
Total Value
$173.59K
Shares Held After
8,961
% of Holdings
54.7%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
10,000
Price
$16.01
Total Value
$160.08K
Shares Held After
17,217
% of Holdings
36.7%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
30,712
Price
$35.49
Total Value
$1.09M
Shares Held After
315,167
% of Holdings
8.9%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
200
Price
$6.30
Total Value
$1.26K
Shares Held After
3,581,293
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
19,650
Price
$6.02
Total Value
$118.32K
Shares Held After
3,581,493
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
45,419
Price
$6.14
Total Value
$279.05K
Shares Held After
3,601,143
% of Holdings
1.2%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
172
Price
$35.00
Total Value
$6.02K
Shares Held After
55,285
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
1,900
Price
$34.84
Total Value
$66.20K
Shares Held After
1,047,205
% of Holdings
0.2%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
23,100
Price
$34.26
Total Value
$791.48K
Shares Held After
1,049,105
% of Holdings
2.2%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
1,000
Price
$9.00
Total Value
$9.00K
Shares Held After
0
% of Holdings
100.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
5,407
Price
$24.50
Total Value
$132.47K
Shares Held After
60,612
% of Holdings
8.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$549.27
Total Value
$131.82K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
14
Price
$546.60
Total Value
$7.65K
Shares Held After
40,753
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
66
Price
$545.96
Total Value
$36.03K
Shares Held After
40,767
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$543.30
Total Value
$239.05K
Shares Held After
40,833
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,081
Price
$542.62
Total Value
$586.57K
Shares Held After
41,273
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,499
Price
$541.60
Total Value
$1.35M
Shares Held After
42,354
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,235
Price
$540.76
Total Value
$1.21M
Shares Held After
44,853
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,309
Price
$539.93
Total Value
$706.77K
Shares Held After
47,088
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
988
Price
$538.51
Total Value
$532.04K
Shares Held After
48,397
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
518
Price
$537.75
Total Value
$278.55K
Shares Held After
49,385
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
110
Price
$536.28
Total Value
$58.99K
Shares Held After
49,903
% of Holdings
0.2%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
2,436
Price
$1.93
Total Value
$4.70K
Shares Held After
14,394
% of Holdings
16.9%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,000
Price
$43.15
Total Value
$43.15K
Shares Held After
149,914
% of Holdings
0.7%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,308
Price
$42.17
Total Value
$139.51K
Shares Held After
150,914
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,792
Price
$41.39
Total Value
$156.96K
Shares Held After
154,222
% of Holdings
2.4%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,900
Price
$40.09
Total Value
$76.17K
Shares Held After
158,014
% of Holdings
1.2%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
135,590
Price
$28.97
Total Value
$3.93M
Shares Held After
7,751,570
% of Holdings
1.7%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
488,654
Price
$28.35
Total Value
$13.85M
Shares Held After
7,887,160
% of Holdings
5.8%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
2,531
Price
$1.93
Total Value
$4.88K
Shares Held After
21,729
% of Holdings
11.6%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
3,277
Price
$1.93
Total Value
$6.32K
Shares Held After
16,689
% of Holdings
19.6%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
7,026
Price
$18.53
Total Value
$130.22K
Shares Held After
1,203,784
% of Holdings
0.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
2,106
Price
$1.93
Total Value
$4.06K
Shares Held After
13,113
% of Holdings
16.1%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
8,543
Price
$4.26
Total Value
$36.43K
Shares Held After
167,750
% of Holdings
4.8%
Showing 1–50 of 2247 transactions (page 1 of 45)